Clinical trial
Genetic Alteration After Systemic Treatment in Breast Cancer
NCT02591966 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Genetic Alteration After Systemic Treatment in Breast Cancer
- Lead sponsor
- Samsung Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2015
- Completion date
- December 31, 2020
- Enrollment
- 350 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer